Raymond James & Associates’s Agile Therapeutics AGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13	Closed	-$25K	–	4326
2021 Q3	$25K	Hold	13	–	–	﹤0.01%	3987
2021 Q2	$36K	Hold	13	–	–	﹤0.01%	3944
2021 Q1	$56K	Sell	13 -1	-7%	-$5.41K	﹤0.01%	3845
2020 Q4	$81K	Hold	14	–	–	﹤0.01%	3588
2020 Q3	$86K	Buy	14 +2	+17%	+$11.5K	﹤0.01%	3399
2020 Q2	$65K	Hold	12	–	–	﹤0.01%	3353
2020 Q1	$44K	Buy	12 +3	+33%	+$17.2K	﹤0.01%	3329
2019 Q4	$43K	Buy	+9	New	+$31.4K	﹤0.01%	3565
2018 Q4	–	Sell	-6	Closed	-$5K	–	3736
2018 Q3	$5K	Hold	6	–	–	﹤0.01%	3604
2018 Q2	$6K	Buy	+6	New	+$21.1K	﹤0.01%	3542
2015 Q2	–	Sell	-14	Closed	-$253K	–	2463
2015 Q1	$253K	Buy	+14	New	+$245K	﹤0.01%	2262